BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Apoptosis
,
Influenza
,
Intestine
,
Biofuel
,
Tamoxifen
,
rs3825942
,
KLK3
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
hormone-refractory prostate cancer
Summary
General Info
Curated Studies
Most Correlated Studies
Prostate cancer cell lines with REST siRNA, mCRPC tissues and patient-derived xenografts
Prostate cancer LnCaP-abl cells depleted of HIPK2 or MED19
Prostate adenocarcinoma castration-resistant and sensitive cell lines
Prostate cancer metastases to different sites characterized by AR, CHGA, ERG and SYP markers
Prostate cancer metastatic tumors with PTEN RB1 TRP53 triple knockout
Explore Curated Studies Results
Literature
Most Relevant Literature
Cabazitaxel: a novel drug for hormone-refractory prostate cancer.
Living with bodily changes in hormone-refractory prostate cancer.
Combination chemotherapy of docetaxel and UFT against hormone refractory prostate cancer].
Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer.
Low-dose docetaxel in combination with dexamethasone for hormone-refractory prostate cancer].
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Fulvestrant in Hormone Refractory Prostate Cancer
Vaccine Treatment for Hormone Refractory Prostate Cancer
A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer
Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer
Tetrathiomolybdate in Hormone Refractory Prostate Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ